Dr. Fuad M. Zeid, MD

Dr. Zeid practices at Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network.

Dr. Zeid's NPI, 1134184526, was assigned on April 19, 2006. Dr. Zeid holds West Virginia license 16998.

Dr. Zeid's primary practice is Cabell Huntington Hospital, at 1340 Hal Greer Boulevard, Huntington, WV 25701 in Cabell County. The practice phone is (304) 526-2000.

Dr. Zeid's primary practice is Cabell Huntington Hospital in Huntington, West Virginia, part of Marshall Health Network. The medical group on file is Marshall Health. Dmand AI also links Dr. Zeid to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Zeid practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. Zeid's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. Zeid is licensed in West Virginia.

CMS data shows 379 Medicare services from Dr. Zeid across 7 procedure codes in 2024, for 165 Medicare patients. Medicare paid $38,079 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 165 Medicare patients who saw Dr. Zeid in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 35% are also on Medicaid. Their average risk score is 2.17, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Zeid's median patient age at 66, with 54% women.

In 2024, Dr. Zeid wrote 831 Medicare Part D claims for 92 patients. 46% of them were for generic drugs. CMS names the drug for 717 of them, across 22 drugs with 11 or more claims each, at $393,005 in total drug cost. In 2023, CMS named 992 claims across 27 drugs.

Dr. Zeid accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 20 papers to Dr. Zeid, published from 2017 to 2025. 2018 was the busiest year, with 6. The most frequent topics are Amphotericin B and Antifungal Agents. Dr. Zeid has published most often in Respir Med Case Rep. Dr. Zeid's most frequent co-authors are Hazim Said Bukamur, MD, Yonas Raru and Abdulrahman Katabi.

CMS Open Payments shows 26 general payments to Dr. Zeid from 9 drug and device companies from 2016 to 2021. Food and beverage make up the largest share, 51% of the total. Covidien LP paid the most, $700.